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identify major factors concerning these measures.  Results: 
Three independent factors were detected; the first com-
prised conductivity, ammonia, and pH, especially when stan-
dardized using CO 2 , the second nitrite/nitrate, and the third 
FE NO . Conductivity and ammonia were highly correlated (r = 
0.968; p  ! 0.001). FE NO provided independent information 
mainly in asthma. The nonspecific EBC markers showed con-
siderable overlap between patient groups and healthy sub-
jects. However, conductivity, ammonia, pH standardized for 
CO 2 and nitrite/nitrate were increased in LTX recipients com-
pared to healthy controls (p  ! 0.05 each).  Conclusions: A 
panel of nonspecific easy-to-obtain exhaled breath markers 
could be reduced to 3 independent factors. The information 
content of conductivity, ammonia, and pH after CO 2 equili-
bration appeared to be similar, while FE NO was independent. 
The increased levels of these biomarkers in LTX might indi-
cate a potential for their use in these patients. 
 Copyright © 2010 S. Karger AG, Basel 
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 Abstract 
 Background: Exhaled breath condensate (EBC) has been 
used for diagnosing and monitoring respiratory disorders. 
For clinical purposes the assessment of easy-to-obtain non-
specific markers seems particularly interesting.  Objectives: 
As these measures are related to each other, our objective 
was to extract the independent information in global EBC 
markers across a range of respiratory disorders.  Methods: 
EBC was collected from patients with asthma (n = 18), chron-
ic obstructive pulmonary disease (n = 17), and cystic fibrosis 
(n = 46), as well as from lung transplant (LTX) recipients (n = 
14) and healthy controls (n = 26). Samples were assessed for 
electrical conductivity, ammonia, pH, and nitrite/nitrate. pH 
was measured after both deaeration with argon and CO 2 
standardization. Additionally, the fraction of exhaled nitric 
oxide (FE NO ) was assessed. Factor analysis was applied to 
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 Introduction 
 Exhaled breath condensate (EBC) contains numerous 
biomarkers that have the potential to play a role in the 
diagnosis and monitoring of disease progression in respi-
ratory disorders or in the evaluation of therapeutic inter-
ventions  [1, 2] . EBC collection has the advantage of being 
completely noninvasive and easily repeatable. However, 
in contrast to the fraction of exhaled nitric oxide (FE NO ), 
which is increasingly used in clinical practice  [3, 4] for 
asthma monitoring, a joint American Thoracic Society 
(ATS)/European Respiratory Society (ERS) task force 
concluded in 2005 that none of the biomarkers in EBC 
would be ready for clinical use  [1] . Many methodological 
questions are still under debate. A major challenge is the 
high dilution of substances in water, with concentrations 
near detection limits, resulting in high variability  [5] . 
One of the drawbacks of most specific EBC markers of 
inflammation or oxidative stress is the need for time-
consuming and technically demanding measurements 
before the results can be used in clinical decision making, 
compared to the immediately available information from 
FE NO .
 EBC also contains markers that can be more quickly 
and easily assessed, e.g. conductivity or pH. These global 
measures may still contain valuable information for the 
assessment of respiratory conditions. However, due to 
their less specific nature, they may be more strongly cor-
related with each other and depend on each other.
 The electrical conductivity of EBC fulfils the require-
ments of an easy- and quick-to-measure nonspecific 
quantity. Moreover, commercially available miniature 
glass measuring cells can provide conductivity data with-
in seconds from a sampling volume of only 50–100   l. So 
far, electrical conductivity in EBC has mainly been as-
sessed to estimate the dilution of nonvolatile hydrophilic 
mediators  [6] . EBC conductivity has been investigated 
less often concerning possible information for the diag-
nosis and monitoring of respiratory diseases.
 As electrical conductivity quantifies ion content it 
might be related to pH, one of the most extensively stud-
ied nonspecific markers in EBC, which has been shown 
to be altered in asthma  [1] . In terms of practical aspects, 
pH is an interesting biomarker in EBC since the analysis 
is not very time consuming, no expensive equipment is 
needed, and samples can be easily stored. However, the 
measurement of pH in EBC might not be trivial due to 
the low ion concentration, difficulties in terms of repro-
ducibility and a lack of standardization of methods, es-
pecially concerning the standardization of the carbon
dioxide content  [7] . Additionally, changes in pH are not 
specific to asthma and have been described in other con-
ditions, e.g. cystic fibrosis (CF)  [8] .
 Ammonia may be responsible for a great part of the 
electrical conductivity of EBC  [5] and seems to be associ-
ated with pH  [9] . Nitrite and nitrate are other nonspe-
cific ionic biomarkers that might be associated with elec-
trical conductivity and respiratory diseases  [10] as well as 
with FE NO  [11] . Electrical conductivity and ammonia are 
supposed to be markedly influenced by oral contamina-
tion  [5] , and EBC analyses are often performed only after 
lyophilization. However, this procedure again prolongs 
and complicates the analysis of EBC biomarkers. With 
regard to practical aspects and for rapid diagnosis, only 
the measurements of raw EBC samples seem realistic. 
Since the nonspecific exhaled biomarkers might be re-
lated to each other, the question of which of these markers 
confers independent information arises.
 Based on these considerations, the aim of our study 
was to evaluate the correlation pattern between electrical 
conductivity and pH (measured with 2 different proto-
cols) and ammonia and nitrite/nitrate in EBC as well as 
FE NO across a range of respiratory diseases. For this pur-
pose we used factor analysis, thereby revealing the inde-
pendent information.
 Materials and Methods 
 Study Subjects and Design 
 The study was performed in cooperation with the pneumolo-
gy departments of Ludwig-Maximilians-University in Munich. 
Adult patients with an established diagnosis of CF (n = 46) were 
recruited from the CF outpatient clinic. They were assessed dur-
ing routine visits and none of them suffered from an exacerbation 
at the time of study. Nine CF patients were currently on steroid 
medication. Similarly, patients with chronic obstructive pulmo-
nary disease (COPD; n = 17) and mild asthma (n = 18) which had 
been diagnosed according to standard clinical criteria were re-
cruited from the pneumology outpatient clinic. None of them suf-
fered from an exacerbation at the time of study. In 5 of the 18 
asthmatics a regular inhalative steroid medication was docu-
mented. Lung transplant (LTX) recipients (n = 14) without signs 
of acute or chronic allograft rejection were recruited from a spe-
cialized outpatient clinic for LTX patients during routine control 
visits.
 Moreover, healthy controls (n = 26) in whom the absence of 
respiratory or other relevant disorders was assessed based on their 
clinical history were recruited. In an outpatient clinic setting all 
study participants underwent FE NO measurement followed by 
spirometry. Subsequently, EBC was sampled. The study was ap-
proved by the local Ethics Committee.
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 Exhaled Breath Condensate Measurements 
 EBC was collected during 10 min of tidal breathing (ECo-
Screen; Viasys, Höchberg, Germany) at a collecting temperature 
below –10  °  C while patients were wearing a nose clip. We did not 
use the aluminum collectors provided by the manufacturer but 
used custom-made plastic sampling tubes instead. These tubes 
were made from polypropylene 50-ml centrifuge tubes and large 
pipette tips that are normally used in cell biological work. These 
had been additionally cleaned with distilled water and isopropa-
nol prior to use, and measurements of conductivity had shown 
that no additional contribution arose from these tubes. A fraction 
of the sample was stored at –32   °   C for performing the assay for 
nitrate and nitrite.
 Electrical Conductivity 
 Electrical conductivity was analyzed immediately after sam-
pling using a miniature glass measuring cell (LDM/S; WTW, 
Weilheim, Germany) at a temperature of 25  °  C. After cleaning the 
measuring cell with distilled water, a fraction of the sample (20–
30   l) was aspirated to remove the water and was subsequently 
discarded. Then, a new portion of the sample was aspirated for the 
measurement.
 Ammonia 
 Ammonia was determined by the classic Berthelot reaction 
involving phenol, sodium hypochlorite, and sodium pentacya-
nonitrosylferrat (III). In 50-  l samples of EBC the amount of 
NH 4 + ions was analyzed photometrically at 620 nm (UV-1602; 
Shimadzu, Duisburg, Germany) after incubation (pH 11.8–12.4, 
50  °  C, 1 h). Four standards and 1 blank value treated in the same 
way as the samples were used to derive the final concentrations. 
The detection limit was 5 ng NH 4 + in 50   l and the standard de-
viation of repeated measurements about 2.5%.
 pH Value 
 pH was determined using a pH electrode (InLab TM Micro; 
Mettler-Toledo, Giessen, Germany) after equilibration with argon 
(Argon 5.0; Linde, Wiesbaden, Germany) for at least 30 min until 
a plateau was reached. This was followed by a second pH measure-
ment after gassing with 2.5% CO 2 in argon (Argomag K; Linde) 
after equilibration for at least 30 min until a plateau was reached. 
 Nitrite/Nitrate 
 Nitrite and nitrate were analyzed using a chemiluminescence 
analyzer (NOA 280; Sievers, Boulder, Colo., USA) according to 
the manufacturer’s instructions. Five microliters of EBC were in-
jected with a Hamilton syringe into a purge vessel attached to the 
device. Nitrite and nitrate were converted to nitric oxide (NO) us-
ing a saturated solution of VCl 3 in 0.8  M HCl. Nitrite alone was 
converted to NO using a 1% w/v solution of KI in acetic acid. Zero 
values were measured using N 2 gas. Final concentrations given as 
  M were calculated using appropriate nitrite and nitrate stan-
dards. Nitrate levels were derived by subtracting nitrite levels 
from the combined nitrite/nitrate levels.
 FE NO Measurement 
 FE NO was determined during a single exhalation using a NOA 
280 according to international guidelines  [3] . After inhaling am-
bient air, subjects expired through a mouthpiece against a positive 
pressure aiming to achieve a flow rate of 50 ml/s under visual con-
trol on a computer screen. Ambient air levels normally showed 
NO levels  ! 15 ppb and a correlation analysis showed no relation-
ship between FE NO and ambient air NO. Measurements were per-
formed at least in triplicate. The mean of 3 reproducible values 
was taken for analysis. Acceptable measurements had to show a 
clearly identifiable plateau (within 10% of each other, typically 
 ! 5%) and a flow rate within 10% (typically  ! 5%) of the target rate 
during the plateau measurement. The analyzer was calibrated 
regularly using a certified calibration gas (Linde AG, Munich, 
Germany).
 Spirometry 
 Forced vital capacity (FVC) and forced expiratory volume in
1 s (FEV 1 ) were determined (MasterLab TM ; Jaeger, Würzburg, 
Germany) following established guidelines, and FVC %pred, 
FEV 1 %pred, and FEV 1 /FVC were recorded  [12] . At least 3 techni-
cal acceptable flow-volume maneuvers were performed and the 
highest values were taken.
 Analysis 
 Results are presented as proportions or as mean values and 
standard deviations (SD). Values of nitrate/nitrite, nitrite, and 
FE NO were log 10 -transformed to achieve a normal distribution. 
Correspondingly, geometric mean values and standard devia-
tions (expressed as factors with regard to the mean value and in-
dicated by the symbol  & ) are presented. Differences between 
groups were assessed using a   2 test and analysis of variance 
(ANOVA). For post hoc analyses Bonferroni tests were used if 
variances were homogeneous; otherwise, Tamhane T2 tests were 
performed. p  ! 0.05 was considered statistically significant.
 Factor analysis is a standard multivariate statistical procedure 
which aims to condense information contained in larger sets of 
variables. In essence, the procedure uses the information regard-
ing which variables are correlated with each other. From this pat-
tern of correlations a set of underlying factors is derived by requir-
ing that correlated variables represent 1 factor and uncorrelated 
variables belong to different factors. In general, this results in a 
reduction of the dimensionality of the data set. In the common 
approach of principal component analysis (see below) the factors 
represent the directions in the data space in which most of the 
variation of the data is located. To achieve the reduction in dimen-
sionality, a cutoff value for variation is used. Below this cutoff 
value all further variation is considered noise. For this purpose 
the so-called eigenvalues are applied (see technical description 
below). Ideally, factor analysis identifies a few independent fac-
tors, each of which explains the correlations between a group of 
variables. Correspondingly, the underlying factors are mutually 
independent linear combinations of variables.
 In the present study the variables were different markers of 
exhaled breath, and factor analysis was used to reveal indepen-
dent statistical factors that explained the pattern of correlations 
between these markers. These factors, fewer in number than the 
markers, would then indicate statistically independent patho-
physiological features and mechanisms. It is important to note 
that the approach of factor analysis has already been used in var-
ious areas of respiratory research  [13, 14] .
 Prior to the factor analysis Pearson correlation coefficients (r) 
were calculated and all statistically significant coefficients  1 0.8 
are reported in the text. In technical terms, correlation coefficients 
were further analyzed by principal component factor analysis fol-
 Dressel  /Müller  /Fischer  /Römmelt  /
Hohlfeld  /Behr  /Huber  /Nowak  /Jörres  
Respiration 2010;80:401–409404
lowed by rotation according to the standard varimax criterion. As 
outlined above, the correlation between variables is attributed to 
their common dependence on independent hypothetical entities 
termed factors. The correlation coefficients between the variables 
and the factors are called factor loadings. Ideally, each variable has 
a high loading on 1 factor, while its loadings on all the other fac-
tors are low. The number of factors necessary is determined to be 
as small as possible, but large enough to account for most of the 
information within the data; it is usually taken from the number 
of eigenvalues of the correlation matrix with a magnitude  1 1. The 
rotated component matrixes of the principal components are dis-
played. Finally, selected scatter plots of factor scores and single 
biomarkers are shown. Statistical calculations were performed us-
ing SPSS 14.0 (SPSS, Inc., Chicago, Ill., USA).
 Results 
 Table 1 shows the basic characteristics, lung function 
measurements, and exhaled biomarkers in the study 
groups. The distributions of gender and height were com-
parable, whereas age and weight differed significantly be-
tween groups (ANOVA, p  !  0.001 each). FEV 1 %pred and 
FVC %pred were higher in healthy subjects and patients 
with asthma compared to the other groups (p  ! 0.05 each, 
post hoc). In healthy subjects FEV 1 /FVC was higher com-
pared to asthma, COPD, and CF patients, and the ratio 
was additionally higher in asthma than in COPD and CF. 
FEV 1 /FVC was also higher in LTX than in COPD patients 
(p  ! 0.05 each).
 Levels of several biomarkers were elevated in LTX pa-
tients compared to other groups. Conductivity was high-
er compared to healthy subjects and CF patients. Further-
more, pH CO 2 and ammonia were higher in LTX patients 
than in healthy subjects, COPD patients, and CF patients. 
Additionally, pH argon was higher in LTX patients than 
in COPD and CF patients (p  ! 0.05 each).
 Nitrite/nitrate values were higher in LTX, COPD, and 
CF patients than in healthy subjects. Nitrite/nitrate was 
additionally lower in asthma than in COPD and CF. Ni-
trite was lower in asthmatics and controls than in CF pa-
tients (p  ! 0.05 each). Finally, FE NO was higher in asthma 
and LTX patients than in CF patients (p  ! 0.05 each).
 Figure 1 displays selected correlations between exhaled 
breath markers. Conductivity and ammonia showed a 
high linear correlation ( fig. 1 a; r = 0.968, p  ! 0.001). Cor-
relation with conductivity was higher for pH CO 2 ( fig. 1 b; 
r = 0.813, p  ! 0.001) than for pH argon (r = 0.511, p  ! 
0.001). For the respective relationships with ammonia 
correlation coefficients were 0.810 and 0.539 (p  ! 0.001 
each). Correlations were also close between pH argon and 
pH CO 2 ( fig. 1 c; r = 0.836, p  ! 0.001) and between log ni-
trate/nitrite and log nitrite ( fig. 1 d; r = 0.891, p  ! 0.001).
 In the factor analysis concerning the exhaled bio-
markers, 3 factors with eigenvalues  1 1 explaining 89% of 
the total variance were extracted. Conductivity, ammo-
nia, pH argon, and pH CO 2 loaded predominantly on 1 
common factor. log nitrate/nitrite and log nitrite loaded 
Table 1.  Basic characteristics, lung function, and exhaled biomarkers in the study groups
Controls (n = 26) Asthma (n = 18) COPD (n = 17) CF (n = 46) LTX (n = 14) p
Females 16 (61.5%) 9 (50.0%) 10 (58.8%) 20 (43.5%) 5 (35.7%) 0.429
Age, years 31.288.3 48.3810.9 65.188.2 32.687.1 54.487.5 <0.001
Height, cm 17487 172810 169811 172810 173811 0.653
Weight, kg 67.5812.2 74.7817.2 80.2818.0 61.5811.1 72.9812.8 <0.001
FEV1 %pred 107.2813.0 96.9817.2 53.8821.9 65.5826.7 69.3817.3 <0.001
FVC %pred 113.0812.7 111.8811.7 79.5818.1 87.5822.4 82.9823.0 <0.001
FEV1/FVC, % 81.286.3 71.089.7 52.9814.8 60.8813.7 70.1813.5 <0.001
Conductivity, S/cm 71.0834.9 94.8845.0 75.8860.6 61.8837.8 149.4874.3 <0.001
pH argon 8.080.7 7.980.9 7.381.3 7.681.2 8.380.1 0.034
pH CO2 5.880.3 5.880.4 5.680.6 5.580.5 6.180.3 0.002
Ammonia, g/ml 0.9580.47 1.4880.77 1.0280.88 0.9880.62 2.1481.00 <0.001
Nitrite/nitrate,  M a 3.73&1.54 3.60&1.77 9.48&2.85 6.52&2.27 5.78&1.53 <0.001
Nitrite,  M a 3.06&1.85 2.62&1.90 7.18&3.36 5.33&2.31 4.28&1.57 <0.001
FENO, ppba 20.7&1.9 43.4&2.6 23.2&2.2 12.9&2.3 25.3&1.4 <0.001
D ata are presented either as the number of subjects or as means 8 SD. p values are from a 2 test or  ANOVA.
a Owing to data distribution the geometric mean and SD are given. SD is expressed as a factor and indicated by &. The geometric 
mean has to be multiplied and divided by this SD factor.
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largely on a second factor. Finally, log FE NO loaded main-
ly on a third factor ( table 2 ).
 Figure 2 shows scatter plots of the factor scores for fac-
tor 1 versus factor 2 and representative exhaled biomark-
ers, i.e. conductivity and log nitrate/nitrite, for the differ-
ent study groups. Factor score 1 and thus conductivity are 
especially high in a subgroup of patients after LTX. Factor 
2 and, correspondingly, log nitrate/nitrite show a tendency 
toward higher values in several COPD patients.  Figure 3 
displays scatter plots of factor score 3 versus factor score 2 
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 Fig. 1. Selected correlations between exhaled breath markers. In a 
large sample of patients with a variety of respiratory diseases as 
well as healthy controls, conductivity correlated generally very 
closely with ammonia ( a ) (r = 0.968, p  ! 0.001) and was also clear-
ly related to pH CO 2 ( b ) (r = 0.813, p  ! 0.001). Correlations were 
also generally close between pH argon and pH CO 2 ( c ) (r = 0.836, 
p  ! 0.001) and between log nitrate/nitrite and log nitrite ( d ) (r = 
0.891, p  ! 0.001). Circles indicate healthy subjects, open triangles 
patients with asthma, closed triangles patients with COPD, lines 
patients with CF, and crosses patients after LTX. 
 Dressel  /Müller  /Fischer  /Römmelt  /
Hohlfeld  /Behr  /Huber  /Nowak  /Jörres  
Respiration 2010;80:401–409406
300
250
200
150
100
50
0
3
2
1
0
–1
–2
–3
0 0.5 1.0 1.5 2.0 2.5
log nitrate/nitrite (μmol/l)
Co
nd
uc
tiv
ity
 (μ
S/
cm
)
Fa
ct
or
 s
co
re
 1
Factor score 2
–2 –1 0 1 2 3 4
a b
 Fig. 2.  a Scatter plot for conductivity versus log nitrate/nitrite.
 b As conductivity, ammonia, pH argon, and pH CO 2 loaded pri-
marily on factor 1 and nitrite and nitrate/nitrite loaded primarily 
on factor 2, the scatter plot for factor score 1 versus factor score 2 
is shown for comparison. Factor score 1 and thus conductivity are 
especially high in a subgroup of patients after LTX. Factor 2 and, 
correspondingly, log nitrate/nitrite show a tendency toward high-
er values in several COPD patients. Circles indicate healthy sub-
jects, open triangles patients with asthma, closed triangles pa-
tients with COPD, lines patients with CF, and crosses patients 
after LTX. 
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 Fig. 3.  a Scatter plot for log FE NO versus log nitrate/nitrite.  b As 
FE NO loaded primarily on factor 3 and nitrite and nitrate/nitrite 
loaded primarily on factor 2, the scatter plot for factor score 3 ver-
sus factor score 2 is shown for comparison. Factor score 3 and log 
FE NO have a tendency toward high values in asthma and low val-
ues in CF. Circles indicate healthy subjects, open triangles pa-
tients with asthma, closed triangles patients with COPD, lines pa-
tients with CF, and crosses patients after LTX. 
 Nonspecific Biomarkers in EBC Respiration 2010;80:401–409 407
and, accordingly, of log FE NO and log nitrate/nitrite. Fac-
tor score 3 and log FE NO have a tendency toward high val-
ues in asthma and low values in CF.
 When including only subjects with asthma in the fac-
tor analysis (n = 18), once again the 3 factors listed above 
could be clearly extracted ( table 3 ). When restricting the 
factor analysis to subjects without asthma (n = 103) only 
2 factors were extracted, with conductivity, ammonia, pH 
argon, and pH CO 2 loading mainly on the first factor and 
log nitrate/nitrite, log nitrite, and log FE NO loading on the 
second factor ( table 4 ).
 Discussion 
 Using factor analysis in a large sample of healthy sub-
jects and patients with various lung diseases, we could re-
duce the information of a number of nonspecific exhaled 
breath measures to 3 distinct dimensions. The first com-
prised conductivity, ammonia, and pH. The second com-
prised nitrite and nitrate, and the third comprised FE NO .
 The correlation between electrical conductivity and 
ammonia in our sample was near perfect, which is in line 
with the finding that ammonia far exceeds the concentra-
tions of any other ion in EBC  [5] . Thus, it can be assumed 
that electrical conductivity is a surrogate marker for am-
monia content throughout diseases that is immediately 
available and easy to measure compared with standard 
ammonia detection methods. When deriving a linear re-
gression equation (r = 0.968) from our data (n = 121), am-
monia in   g/ml was calculated as –0.058 + 0.016  ! con-
ductivity (  S/cm).
 As ammonia is the largest constituent of ionic concen-
tration, it is thought to play an important role in EBC pH 
 [5] . In our samples the association between conductivity, 
ammonia, and pH was highest when pH was standard-
ized for CO 2 . pH in native EBC samples yielded much less 
stable readings. Argon deaeration is the standard proce-
dure to remove volatile components, e.g. CO 2 , and to ob-
tain stable pH readings  [1] . However, it has been shown 
that CO 2 is still variable in samples after argon deaeration 
and that CO 2 is closely related with pH. Therefore, CO 2 
standardization of EBC has been postulated as the most 
reproducible method for pH assessment  [7] . CO 2 stan-
dardization should represent the physiological milieu 
better than deaeration by argon. Under these more phys-
iological conditions an association that is hidden when 
using other methods might be revealed.
 Nitrite and the ratio nitrite/nitrate represented a second 
distinct dimension and FE NO a third when considering 
Table 2.  Rotated component matrix of the 3 principal components 
(factors) for all study participants (n = 121)
F actor
1 2 3
Conductivity 0.913 0.029 0.191
Ammonia 0.922 –0.024 0.179
pH argon 0.797 0.107 –0.213
pH CO2 0.961 0.047 –0.047
log nitrate/nitrite –0.017 0.967 0.080
log nitrite 0.110 0.970 0.033
log FENO 0.044 0.092 0.960
Fac tor loadings are presented and they can vary between –1 
and +1. The magnitude of the factor loading quantifies the cor-
relation between the variable and the factor.
Table 3.  Rotated component matrix of the 3 principal components 
for asthma (n = 18)
F actor
1 2 3
Conductivity 0.958 –0.005 0.078
Ammonia 0.940 –0.030 0.152
pH argon 0.695 0.294 –0.535
pH CO2 0.928 0.086 –0.211
log nitrate/nitrite –0.029 0.951 –0.006
log nitrite 0.112 0.954 0.069
log FENO 0.042 0.108 0.941
Table 4.  Rotated component matrix of the 3 principal components 
for all subjects excluding asthma (n = 103)
F actor
1 2 
Conductivity 0.916 0.096
Ammonia 0.930 0.043
pH argon 0.787 0.047
pH CO2 0.959 0.041
log nitrate/nitrite –0.005 0.948
log nitrite 0.129 0.936
log FENO 0.030 0.498
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our whole study population or the subgroup with asthma. 
However, when analyzing only subjects without asthma, 
FE NO could be attributed to a common factor together 
with the nitrogen oxides. Thus FE NO seems to contain in-
dependent information mainly in asthma, as expected. 
Similarly, FE NO has been found not to be significantly cor-
related with EBC nitrite/nitrate in a study in asthmatic 
children  [11] . In general, changes in nitrogen oxide con-
centrations are known not only to reflect NO formation, 
but also to depend on a variety of other physiological or 
pathophysiological conditions in the airways  [15] .
 A novel finding of our study was the elevated conduc-
tivity in lung transplant recipients in parallel to increased 
ammonia and pH CO 2 . To our knowledge conductivity 
has been used to assess the dilution of EBC samples  [6] 
but not as a potential disease marker. Severe hyperam-
monaemia is a rare complication after lung transplanta-
tion  [16] and in this condition ammonia may also be el-
evated in EBC. The patients included in our study did not 
suffer from this complication; however, affections of the 
liver and kidneys may have contributed to the increased 
ammonia content in EBC. Nephrotoxicity and renal fail-
ure are typical complications of the medication after 
LTX. As electrical conductivity and ammonia are sup-
posed to be markedly influenced by oral contamination 
 [5] , changes in the microbiological flora of the mouth af-
ter lung transplantation may play an additional role. Am-
monia has also been described as being associated with 
pH  [9] . We found an elevated pH CO 2 in LTX patients. In 
LTX airway acidification has been described in bronchi-
olitis obliterans syndrome and in acute allograft rejection 
 [17] . However, another study measuring pH at a standard 
CO 2 partial pressure found no difference between stable 
LTX patients and healthy volunteers  [18] .
 There were no further significant changes concerning 
conductivity, ammonia, and pH in the other diseases un-
der study compared to healthy controls.
 We found elevated nitrite/nitrate levels in COPD and 
CF patients as well as in LTX recipients compared to 
healthy subjects, but not in asthmatics. This may be due 
to the fact that we only examined patients with mild asth-
ma. Our data are in line with another study which found 
normal nitrite levels in patients with mild asthma in con-
trast to elevated values in patients with severe asthma 
 [19] . In the ATS/ERS statement concerning EBC  [1] , ni-
trite and nitrite/nitrate were described as elevated in 
asthma, CF, and bronchiectasis and this was attributed to 
an increased NO metabolism. However, similar to am-
monia, the source of nitrite/nitrate is under debate  [15] . It 
has recently been demonstrated that nitrite in EBC orig-
inates to a large extent in the pharyngo-oral tract as a 
product of nitrate-reducing bacteria  [20] . NO can be 
formed in the pharyngo-oral tract through the reduction 
of salivary nitrite and thus contributes to the level of NO 
in exhaled breath  [21] .
 The influences of disease severity as well as treatment 
effects on single exhaled biomarkers have been described 
 [4, 22, 23] . Our study was not designed to contribute to 
these findings as its scope was the correlation between 
the different biomarkers across a broad range of patients 
with respiratory diseases as well as healthy subjects. Con-
cerning the exhaled biomarkers no differences could be 
detected with regard to asthma, COPD severity, or steroid 
use in asthma or CF in our sample. The only association 
between a biomarker under study and a parameter of dis-
ease severity was suggested by a weak correlation between 
Fe NO and FEV 1 %pred in CF patients (r = 0.276, p = 0.002). 
This is in line with other data  [23] . As stated above, due 
to the inhomogeneous study population and low case 
numbers in subgroups, no conclusions concerning the 
clinical value of single biomarkers to assess disease sever-
ity or treatment effects can be drawn. However, the het-
erogeneity of the study population was a prerequisite to 
study the overall correlation of the biomarkers.
 In conclusion, our data suggested that the information 
contained in a number of nonspecific exhaled breath 
markers that were assessed in a variety of respiratory con-
ditions and in healthy subjects could be reduced to 3 in-
dependent factors. The information content of conductiv-
ity, ammonia, and pH CO 2 seemed to be comparable in 
untreated EBC. FE NO was found to be an independent di-
mension mainly in asthma, but was associated with ni-
trite/nitrate when considering the study population ex-
cluding asthma. Thus our study suggests there are only 2 
or 3 statistically independent factors derived from a 
broader panel of biomarkers. This finding may have im-
plications for research with and clinical use of EBC mark-
ers as the number of biomarkers assessed may be reduced 
in future studies without a significant loss of informa-
tion. There was a considerable overlap in the ranges of 
biomarkers between study subgroups. However, patients 
with LTX showed different values as indicated by in-
creased conductivity, pH CO 2 , ammonia, and nitrite/ni-
trate, suggesting a potential role in the monitoring of LTX.
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